Evaluating the Role of an Objective Lower Gastrointestinal Assessment as Part of ERAS Pathway Following hRAMIE

Documenti analoghi

• The Impact of Early Follow‐Up on Readmission After Gastrointestinal Cancer Surgery: Correspondence
  di: Yizhuo Jiang, et al.
  Pubblicazione: (2024)
• Implementation of a Multidisciplinary Enhanced Recovery After Surgery (ERAS) Program for Cytoreductive Surgery (CRS) With Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  di: Cecily Stockley, et al.
  Pubblicazione: (2024)
• Impact of Reaching the Medicare Part D Drug Benefit Threshold on Surgical Care and Health Outcomes Among Patients Newly Diagnosed With Gastrointestinal Cancer
  di: Eshetu Worku, et al.
  Pubblicazione: (2025)
• Elective Surgical Care Pathways Are Associated With Lower Fracture Rates at Presentation and Contribute to Superior Clinical Outcomes in Metastatic Bone Disease
  di: Annalise G Abbott, et al.
  Pubblicazione: (2026)
• Racial Disparities in the Use of Minimally Invasive Surgery for Gastrointestinal Cancer
  di: Andrei Gurau, et al.
  Pubblicazione: (2024)